These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9845507)

  • 1. Recommendations for chemoprophylaxis after occupational exposure to human immunodeficiency virus: a public health agency perspective.
    Danila RN
    Am J Med; 1997 May; 102(5B):98-101. PubMed ID: 9845507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues complicating the implementation of postexposure prophylaxis.
    L'Ecuyer PB; Fraser VJ
    Am J Med; 1997 May; 102(5B):90-4. PubMed ID: 9845505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.
    Lee LM; Henderson DK
    Drug Saf; 2001; 24(8):587-97. PubMed ID: 11480491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal and ethical issues in revising human immunodeficiency virus postexposure protocols.
    Barnes M
    Am J Med; 1997 May; 102(5B):111-2; discussion 113-4. PubMed ID: 9845511
    [No Abstract]   [Full Text] [Related]  

  • 8. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis.
    Panlilio AL; Cardo DM; Grohskopf LA; Heneine W; Ross CS;
    MMWR Recomm Rep; 2005 Sep; 54(RR-9):1-17. PubMed ID: 16195697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postexposure chemoprophylaxis against HIV: what are the implications for people with AIDS and the organizations that serve them?
    Hodel D
    Am J Med; 1997 May; 102(5B):106-10. PubMed ID: 9845510
    [No Abstract]   [Full Text] [Related]  

  • 11. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 May; 47(RR-7):1-33. PubMed ID: 9603630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postexposure prophylaxis implementation issues: programmatic concerns in hospitals.
    Catalano MT
    Am J Med; 1997 May; 102(5B):95-7. PubMed ID: 9845506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postexposure prophylaxis for HIV exposed health care workers.
    Robbins WA
    AAOHN J; 2000 Mar; 48(3):148-51. PubMed ID: 10846973
    [No Abstract]   [Full Text] [Related]  

  • 14. U.S. Public Health Service updates guidelines for HIV prophylaxis in health care workers.
    Morey SS
    Am Fam Physician; 1998 Dec; 58(9):2165-8. PubMed ID: 9861884
    [No Abstract]   [Full Text] [Related]  

  • 15. Report updates recommendations for health workers exposed to HIV.
    Am J Health Syst Pharm; 1998 Sep; 55(17):1755. PubMed ID: 9867409
    [No Abstract]   [Full Text] [Related]  

  • 16. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(22):468-80. PubMed ID: 8622618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New guidelines issued for occupational exposures.
    AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
    D'Amico R; Pinto LA; Meyer P; Landay AL; Harris AA; Clerici M; Berzofsky JA; Shearer GM; Kessler HA
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):428-30. PubMed ID: 10395147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations.
    Lurie P; Miller S; Hecht F; Chesney M; Lo B
    JAMA; 1998 Nov; 280(20):1769-73. PubMed ID: 9842953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of HIV infection following occupational exposure.
    Fish DN
    Ann Pharmacother; 1993 Oct; 27(10):1243-56. PubMed ID: 8251695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.